A	A	DT	B-NP	O		0	1
cell	cell	NN	I-NP	O		2	6
-	-	HYPH	I-NP	O		6	7
free	free	JJ	I-NP	O		7	11
system	system	NN	I-NP	O		12	18
for	for	IN	B-PP	O		19	22
the	the	DT	B-NP	O		23	26
replication	replication	NN	I-NP	O		27	38
fo	fo	NN	I-NP	O		39	41
bacteriophage	bacteriophage	NN	I-NP	O		42	55
M	M	NN	I-NP	O		56	57
-13	-13	CD	I-NP	O		57	60
duplex	duplex	NN	I-NP	O		61	67
DNA	DNA	NN	I-NP	O		68	71
.	.	.	O	O		71	72

Cell	Cell	NN	B-NP	O		73	77
-	-	HYPH	O	O		77	78
free	free	JJ	B-NP	O		78	82
extracts	extract	NNS	I-NP	O		83	91
from	from	IN	B-PP	O		92	96
M	M	NN	B-NP	B-cell_line		97	98
-13	-13	CD	I-NP	I-cell_line		98	101
am5	am5	NN	I-NP	I-cell_line		102	105
infected	infected	JJ	I-NP	I-cell_line		106	114
Escherichia coli	Escherichia_coli	NNP	I-NP	I-cell_line		115	131
cells	cell	NNS	I-NP	I-cell_line		132	137
which	which	WDT	B-NP	O		138	143
are	be	VBP	B-VP	O		144	147
highly	highly	RB	I-VP	O		148	154
concentrated	concentrate	VBN	I-VP	O		155	167
on	on	IN	B-PP	O		168	170
cellophane	cellophane	NN	B-NP	O		171	181
membrane	membrane	NN	I-NP	O		182	190
disks	disk	NNS	I-NP	O		191	196
replicate	replicate	VBP	B-VP	O		197	206
efficiently	efficiently	RB	B-NP	O		207	218
endogenous	endogenous	JJ	I-NP	O		219	229
M	M	NN	I-NP	O		230	231
-13	-13	CD	I-NP	O		231	234
duplex	duplex	NN	I-NP	O		235	241
DNA	DNA	NN	I-NP	O		242	245
.	.	.	O	O		245	246

If	If	IN	B-SBAR	O		247	249
the	the	DT	B-NP	O		250	253
reaction	reaction	NN	I-NP	O		254	262
is	be	VBZ	B-VP	O		263	265
carried	carry	VBN	I-VP	O		266	273
out	out	RP	B-PRT	O		274	277
in	in	IN	B-PP	O		278	280
the	the	DT	B-NP	O		281	284
presence	presence	NN	I-NP	O		285	293
of	of	IN	B-PP	O		294	296
bromodeoxyuridine	bromodeoxyuridine	NN	B-NP	O		297	314
triphosphate	triphosphate	NN	I-NP	O		315	327
,	,	,	O	O		327	328
the	the	DT	B-NP	O		329	332
majority	majority	NN	I-NP	O		333	341
of	of	IN	B-PP	O		342	344
the	the	DT	B-NP	O		345	348
label	label	NN	I-NP	O		349	354
is	be	VBZ	B-VP	O		355	357
found	find	VBN	I-VP	O		358	363
in	in	IN	B-PP	O		364	366
two	two	CD	B-NP	O		367	370
classes	class	NNS	I-NP	O		371	378
of	of	IN	B-PP	O		379	381
hybrid	hybrid	NN	B-NP	B-protein		382	388
DNA	DNA	NN	I-NP	I-protein		389	392
molecules	molecule	NNS	I-NP	I-protein		393	402
in	in	IN	B-PP	O		403	405
which	which	WDT	B-NP	O		406	411
either	either	CC	O	O		412	418
the	the	DT	B-NP	O		419	422
viral	viral	JJ	I-NP	O		423	428
or	or	CC	O	O		429	431
the	the	DT	B-NP	O		432	435
complementary	complementary	JJ	I-NP	O		436	449
strand	strand	NN	I-NP	O		450	456
is	be	VBZ	B-VP	O		457	459
newly	newly	RB	I-VP	O		460	465
synthesized	synthesize	VBN	I-VP	O		466	477
.	.	.	O	O		477	478

A minor	A_minor	JJ	B-NP	O		479	486
portion	portion	NN	I-NP	O		487	494
of	of	IN	B-PP	O		495	497
the	the	DT	B-NP	O		498	501
label	label	NN	I-NP	O		502	507
is	be	VBZ	B-VP	O		508	510
incorporated	incorporate	VBN	I-VP	O		511	523
into	into	IN	B-PP	O		524	528
fully	fully	RB	B-NP	O		529	534
synthetic	synthetic	JJ	I-NP	O		535	544
duplex	duplex	NN	I-NP	O		545	551
DNA	DNA	NN	I-NP	O		552	555
.	.	.	O	O		555	556

DNA	DNA	NN	B-NP	O		557	560
synthesis	synthesis	NN	I-NP	O		561	570
requires	require	VBZ	B-VP	O		571	579
ATP	ATP	NN	B-NP	O		580	583
and	and	CC	O	O		584	587
is	be	VBZ	B-VP	O		588	590
inhibited	inhibit	VBN	I-VP	O		591	600
by	by	IN	B-PP	O		601	603
nalidixic	nalidixic	JJ	B-NP	O		604	613
acid	acid	NN	I-NP	O		614	618
,	,	,	O	O		618	619
novobiocin	novobiocin	NN	B-NP	O		620	630
,	,	,	O	O		630	631
and	and	CC	O	O		632	635
arabinosylnucleoside	arabinosylnucleoside	NN	B-NP	O		636	656
triphosphates	triphosphate	NNS	I-NP	O		657	670
.	.	.	O	O		670	671

Rifampicin	Rifampicin	NN	B-NP	O		672	682
blocks	block	VBZ	B-VP	O		683	689
preferentially	preferentially	RB	B-ADVP	O		690	704
the	the	DT	B-NP	O		705	708
synthesis	synthesis	NN	I-NP	O		709	718
of	of	IN	B-PP	O		719	721
molecules	molecule	NNS	B-NP	O		722	731
with	with	IN	B-PP	O		732	736
labeled	label	VBN	B-NP	O		737	744
complementary	complementary	JJ	I-NP	O		745	758
strands	strand	NNS	I-NP	O		759	766
.	.	.	O	O		766	767

A	A	DT	B-NP	O		768	769
similar	similar	JJ	I-NP	O		770	777
effect	effect	NN	I-NP	O		778	784
is	be	VBZ	B-VP	O		785	787
observed	observe	VBN	I-VP	O		788	796
upon	upon	IN	B-PP	O		797	801
addition	addition	NN	B-NP	O		802	810
of	of	IN	B-PP	O		811	813
the	the	DT	B-NP	O		814	817
helix	helix	NN	I-NP	B-protein		818	823
-	-	HYPH	O	I-protein		823	824
destabilising	destabilise	VBG	B-VP	I-protein		824	837
M	M	NN	B-NP	I-protein		838	839
-13	-13	CD	I-NP	I-protein		839	842
gene	gene	NN	I-NP	I-protein		843	847
V	V	NN	I-NP	I-protein		848	849
protein	protein	NN	I-NP	I-protein		850	857
.	.	.	O	O		857	858

In	In	IN	B-PP	O		859	861
contrast	contrast	NN	B-NP	O		862	870
,	,	,	O	O		870	871
addition	addition	NN	B-NP	O		872	880
of	of	IN	B-PP	O		881	883
E. coli	E._coli	NNP	B-NP	O		884	891
helix	helix	NN	I-NP	B-protein		892	897
-	-	HYPH	O	I-protein		897	898
destabilising	destabilise	VBG	B-VP	I-protein		898	911
protein	protein	NN	B-NP	I-protein		912	919
(	(	(	O	O		920	921
Eco	Eco	NN	B-NP	B-protein		921	924
HD	HD	NN	I-NP	I-protein		925	927
-	-	HYPH	B-NP	I-protein		927	928
protein	protein	NN	I-NP	I-protein		928	935
)	)	)	O	O		935	936
stimulates	stimulate	VBZ	B-VP	O		937	947
the	the	DT	B-NP	O		948	951
synthesis	synthesis	NN	I-NP	O		952	961
of	of	IN	B-PP	O		962	964
both	both	DT	B-NP	O		965	969
types	type	NNS	I-NP	O		970	975
of	of	IN	B-PP	O		976	978
hybrid	hybrid	NN	B-NP	B-protein		979	985
DNA	DNA	NN	I-NP	I-protein		986	989
molecules	molecule	NNS	I-NP	I-protein		990	999
as	as	RB	B-CONJP	O		1000	1002
well	well	RB	I-CONJP	O		1003	1007
as	as	IN	I-CONJP	O		1008	1010
the	the	DT	B-NP	O		1011	1014
formation	formation	NN	I-NP	O		1015	1024
of	of	IN	B-PP	O		1025	1027
fully	fully	RB	B-NP	O		1028	1033
synthetic	synthetic	JJ	I-NP	O		1034	1043
duplex	duplex	NN	I-NP	O		1044	1050
DNA	DNA	NN	I-NP	O		1051	1054
.	.	.	O	O		1054	1055

